| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Revenue | 7,567.93 | 6,712.63 | 6,403.23 | 7,989.23 |
yoy growth (%) | 12.74 | 4.83 | -19.85 | 30.64 |
Raw materials | -2,999.45 | -2,665.99 | -2,378.59 | -2,425.49 |
As % of sales | 39.63 | 39.71 | 37.14 | 30.35 |
Employee costs | -1,107.39 | -1,072.32 | -1,021.92 | -914.47 |
As % of sales | 14.63 | 15.97 | 15.95 | 11.44 |
Other costs | -1,570.74 | -1,670.08 | -1,655.21 | -1,750.62 |
As % of sales (Other Cost) | 20.75 | 24.87 | 25.84 | 21.91 |
Operating profit | 1,890.34 | 1,304.23 | 1,347.5 | 2,898.64 |
OPM | 24.97 | 19.42 | 21.04 | 36.28 |
Depreciation | -150.81 | -138.53 | -118.2 | -104.93 |
Interest expense | -265.89 | -256.39 | -190.89 | -152.6 |
Other income | 396.23 | 606.78 | 180.42 | 148.23 |
Profit before tax | 1,869.86 | 1,516.09 | 1,218.82 | 2,789.34 |
Taxes | -294.31 | -180.09 | -204.47 | -412.28 |
Tax rate | -15.73 | -11.87 | -16.77 | -14.78 |
Minorities and other | 0 | 0 | 0 | 0 |
Adj. profit | 1,575.55 | 1,335.99 | 1,014.34 | 2,377.05 |
Exceptional items | 73.89 | 18.55 | 0 | -236.45 |
Net profit | 1,649.44 | 1,354.54 | 1,014.34 | 2,140.6 |
yoy growth (%) | 21.77 | 33.53 | -52.61 | 44.21 |
NPM | 21.79 | 20.17 | 15.84 | 26.79 |
Here are some of the stocks that may see significant price movement today: Polycab India, Tata Steel, Dalmia Bharat, etc.
Here are some of the stocks that may see significant price movement today: Glenmark Pharma, Rail Vikas Nigam, Birla Corp, etc.
At around 2.19 PM, Glenmark Pharma was trading 2.97% higher at ₹2,112.90 per piece, against the previous close of ₹2,051.90 on NSE.
Operating performance was slightly weaker, with EBITDA dipping 1.4% to ₹580 crore from ₹588.2 crore.
Here are some of the stocks that may see significant price movement today: Glenmark Pharmaceuticals, Vedanta, Inox Wind, etc.
The compound is currently in Phase 1B clinical trials, being studied for multiple myeloma, a tough-to-treat form of blood cancer.
Here are some of the stocks that may see significant price movement today: Tata Consultancy Services, IREDA, Glenmark Pharma, etc.
Here are some of the stocks that may see significant price movement today: Glenmark Pharma, Ashok Leyland, NTPC, etc.
ISB 2001 is a tri-specific antibody therapeutic for targeting BCMA and CD38 on myeloma cells, as well as CD3 on T cells.
The reshuffle comes after VS Mani, the company's current chief, announced early retirement; he will officially retire as chief on May 26, 2025 after an eight-year career with the company.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
